Medtronic (MDT) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -16.79% |
| Oct 24, 2025 | 32.00% |
| Jul 25, 2025 | -1.41% |
| Apr 25, 2025 | -18.50% |
| Jan 24, 2025 | 1.96% |
| Oct 25, 2024 | 21.95% |
| Jul 26, 2024 | 59.27% |
| Apr 26, 2024 | -50.79% |
| Jan 26, 2024 | 46.76% |
| Oct 27, 2023 | 14.45% |
| Jul 28, 2023 | -33.05% |
| Apr 28, 2023 | -3.25% |
| Jan 27, 2023 | 181.88% |
| Oct 28, 2022 | -53.22% |
| Jul 29, 2022 | -37.53% |
| Apr 29, 2022 | 0.61% |
| Jan 28, 2022 | 12.60% |
| Oct 29, 2021 | 122.84% |
| Jul 30, 2021 | -50.42% |
| Apr 30, 2021 | 7.48% |
| Jan 29, 2021 | 224.27% |
| Oct 30, 2020 | -0.58% |
| Jul 31, 2020 | -31.75% |
| Apr 24, 2020 | -71.59% |
| Jan 24, 2020 | 44.23% |
| Oct 25, 2019 | 65.55% |
| Jul 26, 2019 | -29.97% |
| Apr 26, 2019 | -8.46% |
| Jan 25, 2019 | 14.41% |
| Oct 26, 2018 | 4.22% |
| Jul 27, 2018 | -28.69% |
| Apr 27, 2018 | 190.99% |
| Jan 26, 2018 | -178.68% |
| Oct 27, 2017 | 112.98% |
| Jul 28, 2017 | -14.20% |
| Apr 28, 2017 | 45.94% |
| Jan 27, 2017 | -28.88% |
| Oct 28, 2016 | 16.61% |
| Jul 29, 2016 | -21.94% |
| Apr 29, 2016 | 0.73% |
| Jan 29, 2016 | 110.58% |
| Oct 30, 2015 | -36.59% |
| Jul 31, 2015 | 82,100.00% |
| Apr 24, 2015 | -100.10% |
| Jan 23, 2015 | 18.00% |
| Oct 24, 2014 | -4.94% |